Kazakhstan vs Uzbekistan: The number of people with susceptibility test result for rifampicin
Kazakhstan
5,121
in 2021
Uzbekistan
4,929
in 2021
Kazakhstan rank
28th
Uzbekistan rank
29th
The number of people with susceptibility test result for rifampicin over time
- Kazakhstan
- Uzbekistan
How they compare
Kazakhstan currently reports 5,121 against 4,929 in Uzbekistan, a difference of 192.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Uzbekistan ahead.
Kazakhstan ranks 28th and Uzbekistan ranks 29th of 155 countries.
Kazakhstan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kazakhstan | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5,272 | 4,839 | 433.33 | Kazakhstan |
| 2020s | 4,990 | 4,438 | 552 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kazakhstan or Uzbekistan?
- Kazakhstan, at 5,121 against 4,929 in Uzbekistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kazakhstan and Uzbekistan?
- 192, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Uzbekistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Kazakhstan and Uzbekistan rank globally for the number of people with susceptibility test result for rifampicin?
- Kazakhstan ranks 28th and Uzbekistan ranks 29th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.